A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophyKathryn R. Wagner, Jerry R. Mendell, Wendy King et al.|Annals of Neurology|2008Cited by 466
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathyJerry R. Mendell, Richard J. Barohn, Miriam Freimer et al.|Neurology|2001Cited by 309
Gentamicin‐induced readthrough of stop codons in duchenne muscular dystrophyVinod Malik, Jerry R. Mendell, Louise R. Rodino‐Klapac et al.|Annals of Neurology|2010Cited by 272
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, G. Garcia Gutierrez, Lanyu Zhang et al.|Neurology|2020Cited by 201
Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spotByron J. Gajewski, Richard J. Barohn, Scott Berry et al.|Statistics in Medicine|2015Cited by 25